APYX News and Press, Apyx Medical Corporation From 01/27/22

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...

Advanced Energy Sales of approximately $14.7 to $15.0 million in Q4, up 49% to 52% year-over-year Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and...

Shares of Apyx Medical Corporation (NASDAQ:APYX) traded at a new 52-week high today of $16.23. So far today approximately 161,000 shares have been exchanged, as compared to an average 30-day volume of 65,000 shares. Apyx Medical Corp is an energy technology medical device company. It spe...

Apyx Medical Corp (APYX) Q3 2021 Earnings Conference Call November 11, 2021, 17:00 ET Company Participants Tara Semb - CFO, Treasurer & Secretary Charles Goodwin - President, CEO & Director Conference Call Participants David Turkaly - JMP Securities Matthew O'Brien - Piper Sandler &am...

Advanced Energy Sales increased 88% year-over-year in Q3 Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in t...

Apyx Medical Corporation (NASDAQ:APYX) traded at a new 52-week high today of $14.98. Approximately 161,000 shares have changed hands today, as compared to an average 30-day volume of 122,000 shares. Apyx Medical Corporation (NASDAQ:APYX) defies analysts with a current price ($14.89) 15.4...

Apyx Medical Corporation (NASDAQ:APYX) traded today at a new 52-week high of $14.81. This new high was reached on above average trading volume as 161,000 shares traded hands, while the average 30-day volume is approximately 122,000 shares. Based on a current price of $14.63, Apyx Medical...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announc...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and J-Plasma ® in the hospital surgical marke...